TUESDAY, June 25, 2024 -- A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects...
Vous n'êtes pas connecté
Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the aggressive form of skin cancer, Merkel cell carcinoma.
TUESDAY, June 25, 2024 -- A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects...
Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients...
FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...
FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...
FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free...
DUBAI: La Roche Posay, a leader in dermatological skin care, has announced a strategic partnership with Al Jalila Foundation, a not-for-profit...
DUBAI: La Roche Posay, a leader in dermatological skin care, has announced a strategic partnership with Al Jalila Foundation, a not-for-profit...
The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...
With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western...
A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s Genome Institute of Singapore...